<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0">
  <channel>
    <title>Featured Headlines Feed for GALT</title>
    <link />
    <description>Headlines for Galectin Therapeutics Inc.</description>
    <docs>http://www.rssboard.org/rss-specification</docs>
    <generator>Argotic Syndication Framework 2008.0.2.0, http://www.codeplex.com/Argotic</generator>
    <item>
      <title>Galectin Therapeutics Gets A Bid After Promising Results</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1390851-galectin-therapeutics-gets-a-bid-after-promising-results.aspx?source=itxwebtxt0000015</link>
      <author>Seeking Alpha</author>
      <pubDate>Wed, 01 May 2013 15:51:53 GMT</pubDate>
    </item>
    <item>
      <title>2 Biotech Stocks Announcing Key Early Stage Clinical Developments</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1348331-2-biotech-stocks-announcing-key-early-stage-clinical-developments.aspx?source=itxwebtxt0000015</link>
      <author>Seeking Alpha</author>
      <pubDate>Wed, 17 Apr 2013 14:22:50 GMT</pubDate>
    </item>
    <item>
      <title>Galectin Therapeutics - Great Buying Opportunity</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1303281-galectin-therapeutics-great-buying-opportunity.aspx?source=itxwebtxt0000015</link>
      <author>Seeking Alpha</author>
      <pubDate>Wed, 27 Mar 2013 06:56:01 GMT</pubDate>
    </item>
    <item>
      <title>Market Close: Big Winners &amp; Losers for March 22, 2013 (TOPS, HALO, ANAC, MRIN, SINO, AMBO, GALT, TIB</title>
      <link>http://www.fool.com/news/xt/247wallst/247wallst.com/2013/03/22/market-close-big-winners-losers-for-march-22-2013-tops-halo-anac-mrin-sino-ambo-galt-tibx-dgicb-hsol/.aspx?source=itxwebtxt0000015</link>
      <author>247wallst</author>
      <pubDate>Fri, 22 Mar 2013 16:26:51 GMT</pubDate>
    </item>
    <item>
      <title>Benzinga's Small Cap Movers for Tuesday March 5, 2013</title>
      <link>http://www.fool.com/news/xt/benzinga/www.benzinga.com/trading-ideas/long-ideas/13/03/3392560/benzingas-small-cap-movers-for-tuesday-march-5-2013.aspx?source=itxwebtxt0000015</link>
      <author>Benzinga</author>
      <pubDate>Tue, 05 Mar 2013 18:38:42 GMT</pubDate>
    </item>
    <item>
      <title>4 Stocks Under $10 Spiking Higher</title>
      <link>http://www.fool.com/news/xt/thestreet/www.stockpickr.com/4-stocks-under-10-spiking-higher.html-0.aspx?puc=aol&amp;cm_ven=aol&amp;source=itxwebtxt0000015</link>
      <author>TheStreet</author>
      <pubDate>Tue, 05 Mar 2013 14:26:00 GMT</pubDate>
    </item>
    <item>
      <title>Aegis Capital Reiterates Buy Rating on Galectin Therapeutics After FDA Approval</title>
      <link>http://www.fool.com/news/xt/benzinga/www.benzinga.com/analyst-ratings/analyst-color/13/03/3390946/aegis-capital-reiterates-buy-rating-on-galectin-therapeu.aspx?source=itxwebtxt0000015</link>
      <author>Benzinga</author>
      <pubDate>Tue, 05 Mar 2013 10:37:18 GMT</pubDate>
    </item>
    <item>
      <title>Galectin Therapeutics Announces Discovery Program for New Anti-Galectin Drugs in Collaboration with</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/02/19/galectin-therapeutics-announces-discovery-program-/.aspx?source=itxwebtxt0000015</link>
      <author>DailyFinance</author>
      <pubDate>Tue, 19 Feb 2013 09:44:17 GMT</pubDate>
    </item>
    <item>
      <title>Galectin Therapeutics Announces Discovery Program for New Anti-Galectin Drugs in Collaboration with</title>
      <link>http://www.fool.com/news/xt/benzinga/www.benzinga.com/news/13/02/3344282/galectin-therapeutics-announces-discovery-program-for-new-anti-galectin-drugs-in-.aspx?source=itxwebtxt0000015</link>
      <author>Benzinga</author>
      <pubDate>Tue, 19 Feb 2013 09:01:21 GMT</pubDate>
    </item>
    <item>
      <title>Galectin Therapeutics Executive Chairman, James Czirr to Appear on “The RedChip Money Report” on FOX</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/02/07/galectin-therapeutics-executive-chairman-james-czi/.aspx?source=itxwebtxt0000015</link>
      <author>DailyFinance</author>
      <pubDate>Thu, 07 Feb 2013 18:20:45 GMT</pubDate>
    </item>
    <item>
      <title>2 Small-Cap Biotech Companies With Zero Debt And At Least $10 Million In Cash</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1150101-2-small-cap-biotech-companies-with-zero-debt-and-at-least-10-million-in-cash.aspx?source=itxwebtxt0000015</link>
      <author>Seeking Alpha</author>
      <pubDate>Fri, 01 Feb 2013 10:36:55 GMT</pubDate>
    </item>
    <item>
      <title>Galectin Therapeutics Inc. Announces Submission of an Investigational New Drug (IND) Application for</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/01/31/galectin-therapeutics-inc-announces-submission-of-/.aspx?source=itxwebtxt0000015</link>
      <author>DailyFinance</author>
      <pubDate>Thu, 31 Jan 2013 09:21:03 GMT</pubDate>
    </item>
    <item>
      <title>Galectin Therapeutics Submits IND Application for Treatment of Fatty Liver Disease</title>
      <link>http://www.fool.com/news/xt/benzinga/www.benzinga.com/news/13/01/3292500/galectin-therapeutics-submits-ind-application-for-treatment-of-fatty-liver-diseas.aspx?source=itxwebtxt0000015</link>
      <author>Benzinga</author>
      <pubDate>Thu, 31 Jan 2013 09:02:22 GMT</pubDate>
    </item>
    <item>
      <title>Galectin Therapeutics Inc. Announces Publication of Galectin Symposium Proceedings by the American C</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/01/28/galectin-therapeutics-inc-announces-publication-of/.aspx?source=itxwebtxt0000015</link>
      <author>DailyFinance</author>
      <pubDate>Mon, 28 Jan 2013 09:21:02 GMT</pubDate>
    </item>
    <item>
      <title>Galectin Therapeutics Publishes Proceeds by ACS on Symposium</title>
      <link>http://www.fool.com/news/xt/benzinga/www.benzinga.com/news/13/01/3279049/galectin-therapeutics-publishes-proceeds-by-acs-on-symposium.aspx?source=itxwebtxt0000015</link>
      <author>Benzinga</author>
      <pubDate>Mon, 28 Jan 2013 09:04:29 GMT</pubDate>
    </item>
    <item>
      <title>New Potential Therapy for Diabetic Kidney Disease: Galectin Therapeutics Announces Anti-Galectin Dru</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/01/22/new-potential-therapy-for-diabetic-kidney-disease-/.aspx?source=itxwebtxt0000015</link>
      <author>DailyFinance</author>
      <pubDate>Tue, 22 Jan 2013 10:35:36 GMT</pubDate>
    </item>
    <item>
      <title>Galectin Therapeutics Says Anti-Galectin Drug Effective in Preclinical Studies</title>
      <link>http://www.fool.com/news/xt/benzinga/www.benzinga.com/news/13/01/3262133/galectin-therapeutics-says-anti-galectin-drug-effective-in-preclinical-studies.aspx?source=itxwebtxt0000015</link>
      <author>Benzinga</author>
      <pubDate>Tue, 22 Jan 2013 09:04:56 GMT</pubDate>
    </item>
    <item>
      <title>Galectin Therapeutics Appoints Industry Veteran Rex Horton as Executive Director of Regulatory Affai</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/01/15/galectin-therapeutics-appoints-industry-veteran-re/.aspx?source=itxwebtxt0000015</link>
      <author>DailyFinance</author>
      <pubDate>Tue, 15 Jan 2013 09:21:09 GMT</pubDate>
    </item>
    <item>
      <title>Galectin Therapeutics Receives US Patent for Second Drug Class to Treat Chronic Liver Disease with F</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2012/11/26/galectin-therapeutics-receives-us-patent-for-secon/.aspx?source=itxwebtxt0000015</link>
      <author>DailyFinance</author>
      <pubDate>Mon, 26 Nov 2012 09:51:17 GMT</pubDate>
    </item>
    <item>
      <title>Galectin Therapeutics Presents New Data on the Treatment of Fatty Liver Disease and Fibrosis at AASL</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2012/11/12/galectin-therapeutics-presents-new-data-on-the-tre/.aspx?source=itxwebtxt0000015</link>
      <author>DailyFinance</author>
      <pubDate>Mon, 12 Nov 2012 08:23:05 GMT</pubDate>
    </item>
  </channel>
</rss>
